Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Caris Life Sciences, Inc. | 308,979 | reported | 29 May 2026 | tx 1+1,600 |
| Adaptimmune Therapeutics PLC | 217,222 | reported | 11 Aug 2016 | tx 1+217,222 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 May 2026 | GRANT_AWARD | Caris Life Sciences, Inc. | 1,600 | 15.62 USD | |
| 11 Aug 2016 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 217,222 | 0.00 USD | deriv |